5,8,11,14-eicosatetraynoic acid has been researched along with Prostatic Hyperplasia in 1 studies
5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudry, AA | 1 |
| Wahle, KW | 1 |
| McClinton, S | 1 |
| Moffat, LE | 1 |
1 other study available for 5,8,11,14-eicosatetraynoic acid and Prostatic Hyperplasia
| Article | Year |
|---|---|
Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Cyclooxygenase Inhibitors; Fatty Acids, Unsaturat | 1994 |